Re: Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis.
Khamaisi
Mogher
M
Elad
Sharon
S
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D015986:Confounding Factors, Epidemiologic; D048909:Diabetes Complications / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery; D003920:Diabetes Mellitus / Q000139:chemically induced; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D007568:Jaw / Q000187:drug effects* / Q000473:pathology; D015588:Observer Variation; D056948:Orthognathic Surgical Procedures; D010019:Osteomyelitis / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000601:surgery; D010020:Osteonecrosis / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000601:surgery; D012107:Research Design; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D004164:Diphosphonates